# Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer

> **NCT05889247** · NA · RECRUITING · sponsor: **Zealand University Hospital** · enrollment: 350 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer Metastatic

## Interventions

- **OTHER:** Circulating tumor DNA treatment monitoring

## Key facts

- **NCT ID:** NCT05889247
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-28
- **Primary completion:** 2027-06
- **Final completion:** 2032-06
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05889247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05889247, "Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05889247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
